Science and Enterprise

Tag: biotechnology

  • Pharma, Biotech Ink Deal on Anti-Inflammatory Candidate

    XOMA Ltd., a biotechnology company in Berkeley, California, and Les Laboratoires Servier a French pharmaceutical company, announced an agreement to develop and commercialize XOMA 052, XOMA’s anti-inflammatory drug candidate. XOMA 052 is designed to inhibit the pro-inflammatory cytokine interleukin-1 beta believed to be a primary trigger of pathologic inflammation in multiple diseases. Under the agreement,…

  • Biotech Licenses Natural Anti-Bacterial Compounds

    AMRI, a biotechnology company in Albany, New York agreed to a research and licensing deal with Genentech, a Roche Group company, for AMRI’s anti-bacterial compounds from its natural products sample collection. Under the agreement, Genentech will receive an exclusive license to develop and commercialize potential products from AMRI’s anti-bacterial program. AMRI will also collaborate with…

  • Collaboration Targets New Circulating Tumor Cell Technology

    Massachusetts General Hospital (MGH) in Boston and Veridex LLC, a biotechnology subsidiary of pharmaceutical company Johnson & Johnson  in Raritan, New Jersey said today they plan to develop and commercialize a technology for capturing, counting, and characterizing tumor cells found in patients’ blood. These circulating tumor cells (CTCs) are cancer cells that have detached from…

  • FDA Clears Stem Cell Trial for Macular Degeneration

    Advanced Cell Technology Inc. (ACT), a biotechnology company in Marlborough, Massachusetts, said today that the U.S. Food and Drug Administration (FDA) has cleared its application to test-treat dry age-related macular degeneration using human embryonic stem cells.  Dry age-related macular degeneration (AMD) is the leading cause of vision loss and blindness among Americans who are age…

  • Biotech Lands $5 Million Investment Deal

    Compugen Ltd., a biotechnology company in Tel Aviv, Israel, said today that it will receive $5 million in R&D funding from Baize Investments Ltd., a private Israeli corporation that invests in medical technologies. Compugen is a drug and diagnostic discovery company that bases its work on automated (in silico) analyses and models, including computational biologic…

  • Engineers Develop Biomarker Breathalyzer Diagnostics

    Researchers at Purdue University in West Lafayette, Indiana are developing breath-analysis technology to diagnose patients in real time by detecting chemical compounds called biomarkers in a person’s respiration. Carlos Martinez, an assistant professor of materials engineering leads the project for Purdue, and is working with colleagues at the National Institute of Standards and Technology, a…

  • FDA Approval Sought for Heart Failure Device

    HeartWare International Inc., in Sydney, Australia says today it submitted a Pre-Market Approval application to the U.S. Food and Drug Administration (FDA) for its HeartWare Ventricular Assist System. The system acts as a bridge to heart transplantation for patients with end-stage heart failure. Premarket approval by FDA is the required process of scientific review to…

  • Indiana Seed Fund Backs Biotech Start Up

    A new biotechnology company, whose work is based on research from the labs of the Indiana University medical school, has received investment backing from an Indiana state fund supporting life science start ups. Aarden Pharmaceuticals in Indianapolis will get $250,000 in early-stage capital from the Indiana Seed Fund. Aarden is developing technologies that attack difficult-to-treat…

  • Biotech Makes Available Stem Cell Lines to Researchers

    BioTime Inc., a biotechnology company in Alameda, California said today it concluded an agreement to make five research-grade human embryonic stem (hES) cell lines available to University of California (UC) system researchers. These lines are genetically identical to the Good Management Practice (GMP)-compliant hES cell lines that will be made available to researchers in California…

  • NFL Grant Funds Bioengineered Spinal Disc Research

    Researchers from Cornell University in Ithaca, New York and Weill Cornell Medical College in New York City have received a $100,000 grant from NFL Charities to research tissue engineering for spinal injuries. NFL Charities is the charitable foundation of the National Football League owners. The research aims to create a living, bioengineered intervertebral disc (IVD)…